Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China
· Delayed Price · Currency is CNY 30.38
-3.02 (-9.04%)
At close: May 30, 2025, 2:57 PM CST
Suzhou Fushilai Pharmaceutical Company Description
Suzhou Fushilai Pharmaceutical Co., Ltd. engages in the manufacture and sale of biopharmaceutical products in China.
It primarily focuses on manufacturing Alpha Lipoic Acid, L-Carnosine, and Phosphatidylcholine series of products.
Its products are primarily used in medicines, dietary supplements, cosmetics, and other fields. The company also exports its products to Europe, America, Southeast Asia, and other countries.
Suzhou Fushilai Pharmaceutical Co., Ltd. was founded in 1997 and is based in Changshu, China.
Suzhou Fushilai Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 1997 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 524 |
| CEO | Xiangyun Qian |
Contact Details
Address: No.16 Haiwang Road Changshu, 215500 China | |
| Phone | 86 51 2528 35990 |
| Website | fuslai.com |
Stock Details
| Ticker Symbol | 301258 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000058W2 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Xiangyun Qian | Chairman and GM |
| Aijin Bian | Deputy GM, Board Secretary, Financial Director, Head of Accounting Agency and Director |
| Jiangang Lu | Deputy GM of Production and Director |
| Yi Qian | Chairman of the Board of Supervisors and Director of Human Resources and Administration |